Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age

Vaccine

Volumn 24, Issue 16, 2006, Pages 3258-3260

  Heininger, Ulrich ^a   Desgrandchamps, Daniel ^a,b   Schaad, Urs B ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Seroprevalence; Transplacental immunity; Varicella; Varicella Zoster virus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; VARICELLA ZOSTER VACCINE;

ARTICLE; BLOOD SAMPLING; CHICKENPOX; CONTROLLED STUDY; HUMAN; INFANT; NEWBORN; PASSIVE IMMUNIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROPREVALENCE; SWITZERLAND; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; CHICKENPOX; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; SEROEPIDEMIOLOGIC STUDIES; SWITZERLAND; TIME FACTORS;

EID: 33645058891     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.026     Document Type: Article

References (15)

1. J. Bonhoeffer, G. Baer, B. Muehleisen, C. Aebi, D. Nadal, and U.B. Schaad Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents Eur J Pediatr 164 2005 366 370
2. G. Enders, E. Miller, J. Cradock-Wtason, I. Bolley, and M. Ridehalgh Consequences of varicella and herpes zoster in pregnancy: prospective study in 1739 cases Lancet 343 1994 1548 1551
3. A.L. Pastuszak, M. Levy, B. Schick, C. Zuber, M. Feldkamp, and J. Gladstone Outcome after maternal varicella infection in the first 20 weeks of pregnancy N Engl J Med 330 1994 901 905
4. S. Black, H. Shinefield, P. Ray, E. Lewis, J. Hansen, and J. Schwalbe Postmarketing evaluation of the safety and effectiveness of varicella vaccine Pediatr Infect Dis J 18 1999 1041 1046
5. D. Desgrandchamps, U.B. Schaad, J. Glaus, G. Tusch, and U. Heininger Seroprävalenz von IgG-Antikörpern gegen Masern, Mumps und Röteln bei Schweizer Kindern in den ersten 16 Lebensmonaten Schweiz Med Wochenschr 130 2000 1479 1486
6. U. Heininger, C. Braun-Fahrlander, D. Desgrandchamps, J. Glaus, L. Grize, and P. Wutzler Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity Pediatr Infect Dis J 20 2001 775 778
7. C. Aebi, K. Fischer, M. Gorgievski, L. Matter, and K. Mühlemann Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data Vaccine 19 2001 3097 3103
8. B. Leineweber, V. Grote, U.B. Schaad, and U. Heininger Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns Pediatr Infect Dis J 23 2004 361 363
9. H.E. Evans, S.O. Akpata, and L. Glass Serum immunoglobulin levels in premature and full-term infants Am J Clin Pathol 56 1971 416 418
10. N. Linder, L. Sirota, Y. Aboudy, B. German, T. Lifshits, and B.S. Barnea Placental transfer of maternal rubella antibodies to full-term and preterm infants Infection 27 1999 203 207
11. J. Klinge, S. Lugauer, K. Korn, U. Heininger, and K. Stehr Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age Vaccine 18 2000 3134 3140
12. H. Gans, L. Yasukawa, M. Rinki, R. DeHovitz, B. Forghani, and J. Beeler Immune responses to measles and mumps vaccination of infants at 6, 9 and 12 months J Infect Dis 184 2001 817 826
13. Schweizerische Kommission für Impffragen. Varizellenimpfung. BAG Bull 2004;45:846-8.
14. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut 2005. Epidem Bull 2005;30:257-72.
15. K.M. Posfay-Barbe, U. Heininger, C. Aebi, D. Desgrandchamps, B. Vaudaux, and C.A. Siegrist How do physicians immunize their own children? Differences among pediatricians and nonpediatricians Pediatrics 116 5 2005 e623 e633